GFI1B mutation causes autosomal dominant gray platelet syndrome

Authors

  • F. Aminkeng

    1. The Canadian Pharmacogenomic Network for Drug Safety (CPNDS), Center for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
    Search for more papers by this author

e-mail: folefac@cmmt.ubc.ca

Abstract

A dominant-negative GFI1B mutation in the gray platelet syndrome.

Monteferrari, et al. (2014)

N Engl J Med; 370(3):245–253.

Ancillary